Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
Condition(s):Restless Legs SyndromeLast Updated:January 11, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Restless Legs SyndromeLast Updated:January 11, 2023Completed
Condition(s):Restless Legs SyndromeLast Updated:April 4, 2018Completed
Condition(s):Restless Legs SyndromeLast Updated:December 16, 2005Completed
Condition(s):Multiple Sclerosis; Restless Legs SyndromeLast Updated:December 2, 2019Withdrawn
Condition(s):Restless Legs Syndrome; End-Stage Renal DiseaseLast Updated:November 2, 2014Completed
Condition(s):Restless Legs SyndromeLast Updated:November 1, 2013Completed
Condition(s):Restless Legs Syndrome; Ekbom Syndrome; Willis-Ekbom DiseaseLast Updated:November 29, 2016Completed
Condition(s):Restless Legs Syndrome; Kidney Failure, ChronicLast Updated:June 17, 2011Completed
Condition(s):Restless Legs SyndromeLast Updated:October 31, 2013Completed
Condition(s):Restless Legs SyndromeLast Updated:July 22, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.